122 related articles for article (PubMed ID: 18844490)
41. Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data.
Kataki A; Gomatos I; Pararas N; Armakolas A; Panousopoulos D; Karantzikos G; Voros D; Zografos G; Markopoulos C; Leandros E; Konstadoulakis M
Clin Genet; 2005 Apr; 67(4):322-9. PubMed ID: 15733268
[TBL] [Abstract][Full Text] [Related]
42. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
43. High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations.
de Juan I; Esteban E; Palanca S; Barragán E; Bolufer P
Breast Cancer Res Treat; 2009 May; 115(2):405-14. PubMed ID: 18528753
[TBL] [Abstract][Full Text] [Related]
44. A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes.
Hondow HL; Fox SB; Mitchell G; Scott RJ; Beshay V; Wong SQ; ; Dobrovic A
BMC Cancer; 2011 Jun; 11():265. PubMed ID: 21702907
[TBL] [Abstract][Full Text] [Related]
45. Sequence Variants of BRCA1 and BRCA2 Genes in Four Iranian Families with Breast and Ovarian Cancer.
Keshavarzi F; Noughani AE; Ayoubian M; Zeinali S
Iran J Public Health; 2011; 40(2):57-66. PubMed ID: 23113073
[TBL] [Abstract][Full Text] [Related]
46. Characterization of
Atshemyan S; Chavushyan A; Berberian N; Sahakyan A; Zakharyan R; Arakelyan A
F1000Res; 2017; 6():29. PubMed ID: 28357044
[No Abstract] [Full Text] [Related]
47. Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2.
Goldgar DE; Easton DF; Deffenbaugh AM; Monteiro AN; Tavtigian SV; Couch FJ;
Am J Hum Genet; 2004 Oct; 75(4):535-44. PubMed ID: 15290653
[TBL] [Abstract][Full Text] [Related]
48. Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation.
Abkevich V; Zharkikh A; Deffenbaugh AM; Frank D; Chen Y; Shattuck D; Skolnick MH; Gutin A; Tavtigian SV
J Med Genet; 2004 Jul; 41(7):492-507. PubMed ID: 15235020
[TBL] [Abstract][Full Text] [Related]
49. Rapid and sensitive detection of BRCA1/2 mutations in a diagnostic setting: comparison of two high-resolution melting platforms.
De Leeneer K; Coene I; Poppe B; De Paepe A; Claes K
Clin Chem; 2008 Jun; 54(6):982-9. PubMed ID: 18403564
[TBL] [Abstract][Full Text] [Related]
50. Genetic Variants in the 3'UTR of
Sánchez-Chaparro MM; Garza-Veloz I; Zayas-Villanueva OA; Martinez-Fierro ML; Delgado-Enciso I; Gomez-Govea MA; Martínez-de-Villarreal LE; Reséndez-Pérez D; Rodríguez-Sánchez IP
Diagnostics (Basel); 2020 May; 10(5):. PubMed ID: 32414209
[TBL] [Abstract][Full Text] [Related]
51. Predicting the Pathogenic Potential of BRCA1 and BRCA2 Gene Variants Identified in Clinical Genetic Testing.
Brookes C; Lai S; Doherty E; Love DR
Sultan Qaboos Univ Med J; 2015 May; 15(2):e218-25. PubMed ID: 26052455
[TBL] [Abstract][Full Text] [Related]
52. The first case report of a large deletion of the BRCA1 gene in Croatia: A case report.
Musani V; Sušac I; Ozretić P; Eljuga D; Levanat S
Medicine (Baltimore); 2017 Dec; 96(48):e8667. PubMed ID: 29310340
[TBL] [Abstract][Full Text] [Related]
53. Classification of rare missense substitutions, using risk surfaces, with genetic- and molecular-epidemiology applications.
Tavtigian SV; Byrnes GB; Goldgar DE; Thomas A
Hum Mutat; 2008 Nov; 29(11):1342-54. PubMed ID: 18951461
[TBL] [Abstract][Full Text] [Related]
54. Establishing a control population to screen for the occurrence of nineteen unclassified variants in the BRCA1 gene by denaturing high-performance liquid chromatography.
Arnold N; Peper H; Bandick K; Kreikemeier M; Karow D; Teegen B; Jonat W
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Dec; 782(1-2):99-104. PubMed ID: 12457999
[TBL] [Abstract][Full Text] [Related]
55. Genetic dissection of the BRCA2 promoter and transcriptional impact of DNA variants.
Fraile-Bethencourt E; Valenzuela-Palomo A; Díez-Gómez B; Infante M; Durán M; Marcos G; Lastra E; Gómez-Barrero S; Velasco EA
Breast Cancer Res Treat; 2018 Aug; 171(1):53-63. PubMed ID: 29766361
[TBL] [Abstract][Full Text] [Related]
56. Novel sequence variants and common recurrent polymorphisms of BRCA2 in Sri Lankan breast cancer patients and a family with BRCA1 mutations.
DE Silva S; Tennekoon KH; Karunanayake EH; DE Silva W; Amarasinghe I; Angunawela P
Exp Ther Med; 2011 Nov; 2(6):1163-1170. PubMed ID: 22977638
[TBL] [Abstract][Full Text] [Related]
57. Advantage of high-resolution melting curve analysis over conformation-sensitive gel electrophoresis for mutational screening of BRCA1 and BRCA2 genes.
de Juan Jiménez I; Cardeñosa EE; Suela SP; González EB; Trejo DS; Lluch OF; Gilabert PB
Clin Chim Acta; 2011 Mar; 412(7-8):578-82. PubMed ID: 21147080
[TBL] [Abstract][Full Text] [Related]
58. BRCA1 gene sequence variation in centenarians.
Vijg J; Perls T; Franceschi C; van Orsouw NJ
Ann N Y Acad Sci; 2001 Apr; 928():85-96. PubMed ID: 11795532
[TBL] [Abstract][Full Text] [Related]
59. Spliceogenic analysis of BRCA1 c.439T>C (rs794727800) variant by High Resolution Melting Analysis.
Minucci A; Mazzuccato G; D'Indinosante M; Di Nardo L; Concolino P; De Bonis M; Urbani A; Scambia G; Fagotti A; Capoluongo E
Mol Biol Rep; 2020 Feb; 47(2):1513-1520. PubMed ID: 31833030
[TBL] [Abstract][Full Text] [Related]
60. False discovery rates for rare variants from sequenced data.
Capanu M; Seshan VE
Genet Epidemiol; 2015 Feb; 39(2):65-76. PubMed ID: 25556339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
